Bortezomib As An Alternate Strategy For Maintenance Therapy. MediCom Oncology Clinical Pearls Podcasts podcast

Artwork

Oncology Medicine MediCom Oncology Multiple Myeloma Science

Player FM - Internet Radio Done Right

40 subscribers

eight 年前已添加！

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

T

TechSurge: Deep Tech VC Podcast

TechSurge: Deep Tech VC Podcast podcast artwork

TechSurge: Deep Tech VC Podcast podcast artwork

1
Understanding the Elegant Math Behind Modern Machine Learning 1:14:43

1 day之前1:14:43

1:14:43

Artificial intelligence is evolving at an unprecedented pace—what does that mean for the future of technology, venture capital, business, and even our understanding of ourselves? Award-winning journalist and writer Anil Ananthaswamy joins us for our latest episode to discuss his latest book Why Machines Learn: The Elegant Math Behind Modern AI . Anil helps us explore the journey and many breakthroughs that have propelled machine learning from simple perceptrons to the sophisticated algorithms shaping today’s AI revolution, powering GPT and other models. The discussion aims to demystify some of the underlying math that powers modern machine learning to help everyone grasp this technology impacting our lives, even if your last math class was in high school. Anil walks us through the power of scaling laws, the shift from training to inference optimization, and the debate among AI’s pioneers about the road to AGI—should we be concerned, or are we still missing key pieces of the puzzle? The conversation also delves into AI’s philosophical implications—could understanding how machines learn help us better understand ourselves? And what challenges remain before AI systems can truly operate with agency? If you enjoy this episode, please subscribe and leave us a review on your favorite podcast platform. Sign up for our newsletter at techsurgepodcast.com for exclusive insights and updates on upcoming TechSurge Live Summits. Links: Read Why Machines Learn, Anil’s latest book on the math behind AI https://www.amazon.com/Why-Machines-Learn-Elegant-Behind/dp/0593185749 Learn more about Anil Ananthaswamy’s work and writing https://anilananthaswamy.com/ Watch Anil Ananthaswamy’s TED Talk on AI and intelligence https://www.ted.com/speakers/anil_ananthaswamy Discover the MIT Knight Science Journalism Fellowship that shaped Anil’s AI research https://ksj.mit.edu/ Understand the Perceptron, the foundation of neural networks https://en.wikipedia.org/wiki/Perceptron Read about the Perceptron Convergence Theorem and its significance https://www.nature.com/articles/323533a0…

MediCom Oncology Clinical Pearls Podcasts « »
Bortezomib as an alternate strategy for maintenance therapy.

7年之前 2:32

分享

MP3•单集首页

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.

… continue reading

53集单集

#Oncology #Medicine #MediCom Oncology #Multiple Myeloma #Science

Artwork

Bortezomib as an alternate strategy for maintenance therapy.

MediCom Oncology Clinical Pearls Podcasts

40 subscribers

published 7年之前

分享

MP3•单集首页

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.

… continue reading

53集单集

#Oncology #Medicine #MediCom Oncology #Multiple Myeloma #Science

Wszystkie odcinki

×

Artwork

1
Third-generation FLT3 inhibitors in clinical development 2:42

6 years之前2:42

2:42

Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.

Artwork

1
CAR T case study in acute myeloid leukemia 5:49

6 years之前5:49

5:49

Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.

Artwork

1
Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi 2:23

6 years之前2:23

2:23

Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.

Artwork

1
How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance 3:58

7 years之前3:58

3:58

In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).

Artwork

1
When to consider iron chelation therapy for a transplant-eligible patient 3:56

7 years之前3:56

3:56

Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.

Artwork

1
53-year-old woman presenting with severe fatigue and bruising 3:58

7 years之前3:58

3:58

Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.

Artwork

1
New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy 4:00

7 years之前4:00

4:00

Dr. O'Reilly discusses the new subcategories of pancreatic cancer that have emerged, and which are laying the groundwork for a biomarker-driven approach to therapy.

Artwork

1
What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics? 2:40

7 years之前2:40

2:40

Dr. O'Reilly discusses the unique pathophysiology of pancreas cancer that must be considered in the development of novel therapeutics.

Artwork

1
Predictors of response to lenalidomide in a non-del(5q) MDS patient 3:03

7 years之前3:03

3:03

Listen as Dr. Goldberg discusses, in just under two minutes, the predictors of response to lenalidomide in a non-del(5q) MDS patient.

Artwork

1
What are the pros and cons of radiation therapy? 2:29

7 years之前2:29

2:29

Listen as Dr. Matasar discusses the pros and cons of radiation therapy, and who should be offered this therapy.

Artwork

1
What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma? 3:01

7 years之前3:01

3:01

Listen as Dr. Matasar discusses survivorship care for patients who have been treated for classical Hodgkin lymphoma, including late effects of treatment.

Artwork

1
Second primary malignancies associated with lenalidomide maintenance 2:53

7 years之前2:53

2:53

Dr. Jacob Laubach discusses second primary malignancies associated with lenalidomide maintenance in the transplant and post-transplant setting.

Artwork

1
Impact of consolidation therapy in patients post-transplant 3:09

7 years之前3:09

3:09

Dr. Laubach discusses the impact of consolidation therapy in patients post-transplant, referencing results of the CTN StaMINA trial.

Artwork

1
Bortezomib as an alternate strategy for maintenance therapy. 2:32

7 years之前2:32

2:32

Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.

Artwork

1
What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma? 2:35

7 years之前2:35

2:35

Listen as Dr. Matasar discusses the future role of brentuximab vedotin in patients with newly diagnosed classical Hodgkin lymphoma.

欢迎使用Player FM

Player FM正在网上搜索高质量的播客，以便您现在享受。它是最好的播客应用程序，适用于安卓、iPhone和网络。注册以跨设备同步订阅。

收听超过500个主题

边探索边听这个节目